Jane O Schell1, Maria Da Silva-Gane, Michael J Germain. 1. Section of Palliative Care and Medical Ethics, University of Pittsburgh School of Medicine, UPMC, Pittsburgh, Pennsylvania, USA. schelljo@upmc.edu
Abstract
PURPOSE OF REVIEW: Elderly patients comprise the fastest growing population initiating dialysis and also experience the worst outcomes, including increased mortality, loss of functional status, and impaired quality of life. Nephrologists are often challenged with how best to engage in dialysis decision-making discussions within this population. Prognostication tools can assist nephrologists in engaging in these discussions, especially in patients for whom survival benefits may be outweighed by the burdens of treatment. RECENT FINDINGS: This review includes the latest research in the survival of elderly patients with and without dialysis; prognostic factors associated with renal progression and survival; and integrative prognostic models to predict both short-term and long-term prognosis. The concept of kidney illness disease trajectory is defined with important outcomes including survival, health-related quality of life, and symptoms with and without dialysis. This prognostic information will then be integrated into an individualized approach to shared decision-making regarding treatment decision-making.(Figure is included in full-text article.) SUMMARY: Treatment decision-making for elderly patients with advanced kidney disease necessitates an active process between nephrologist and patient, incorporating medical information as well as patient preferences. Prognostic information and observational data can facilitate nephrologists' ability to foresee and foretell the illness trajectory both with and without dialysis, further guiding these conversations.
PURPOSE OF REVIEW: Elderly patients comprise the fastest growing population initiating dialysis and also experience the worst outcomes, including increased mortality, loss of functional status, and impaired quality of life. Nephrologists are often challenged with how best to engage in dialysis decision-making discussions within this population. Prognostication tools can assist nephrologists in engaging in these discussions, especially in patients for whom survival benefits may be outweighed by the burdens of treatment. RECENT FINDINGS: This review includes the latest research in the survival of elderly patients with and without dialysis; prognostic factors associated with renal progression and survival; and integrative prognostic models to predict both short-term and long-term prognosis. The concept of kidney illness disease trajectory is defined with important outcomes including survival, health-related quality of life, and symptoms with and without dialysis. This prognostic information will then be integrated into an individualized approach to shared decision-making regarding treatment decision-making.(Figure is included in full-text article.) SUMMARY: Treatment decision-making for elderly patients with advanced kidney disease necessitates an active process between nephrologist and patient, incorporating medical information as well as patient preferences. Prognostic information and observational data can facilitate nephrologists' ability to foresee and foretell the illness trajectory both with and without dialysis, further guiding these conversations.
Authors: Nazanin Noori; Andrew T Yan; Mercedeh Kiaii; Andrea Rathe; Marc B Goldstein; Olugbenga Bello; Ron Wald Journal: Int Urol Nephrol Date: 2017-04-29 Impact factor: 2.370
Authors: Sethu M Madhavan; John F O'Toole; Martha Konieczkowski; Laura Barisoni; David B Thomas; Santhi Ganesan; Leslie A Bruggeman; Matthias Buck; John R Sedor Journal: JCI Insight Date: 2017-07-20
Authors: Melissa W Wachterman; Susan M Hailpern; Nancy L Keating; Manjula Kurella Tamura; Ann M O'Hare Journal: JAMA Intern Med Date: 2018-06-01 Impact factor: 21.873
Authors: Adrian R Levy; Robert M Perkins; Karissa M Johnston; Sean D Sullivan; Vipan C Sood; Wendy Agnese; Mark A Schnitzler Journal: Int J Nephrol Renovasc Dis Date: 2014-07-03
Authors: Kai-Uwe Eckardt; Iain A Gillespie; Florian Kronenberg; Sharon Richards; Peter Stenvinkel; Stefan D Anker; David C Wheeler; Angel L de Francisco; Daniele Marcelli; Marc Froissart; Jürgen Floege Journal: Kidney Int Date: 2015-04-29 Impact factor: 10.612